| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/30/2003 | WO2001094416A3 Human proteins and nucleic acids encoding same |
| 01/30/2003 | WO2001092877A3 Method of identifying and/or isolating stem cells |
| 01/30/2003 | WO2001090359A3 G-protein coupled receptors |
| 01/30/2003 | WO2001081589A3 14911 novel protein kinase molecules and uses therefor |
| 01/30/2003 | WO2001081576A3 Novel g protein-coupled receptor con-218 |
| 01/30/2003 | WO2001079488A3 14257,protein kinase molecules and uses therefor |
| 01/30/2003 | WO2001079286A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 01/30/2003 | WO2001077172A3 Non-endogenous, constitutively activated known g protein-coupled receptors |
| 01/30/2003 | WO2001077161A3 Gtp binding stress-related proteins and methods of use in plants |
| 01/30/2003 | WO2001068853A3 Immunogenic ovarian cancer genes |
| 01/30/2003 | WO2001068835A3 Method for modifying a nucleic acid |
| 01/30/2003 | WO2001064877A9 Human schizophrenia gene |
| 01/30/2003 | WO2001051665A3 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 01/30/2003 | US20030024014 Trangenic wheat for use in generation of disease resistant plants |
| 01/30/2003 | US20030024013 Gene controlling fruit size and cell division in plants |
| 01/30/2003 | US20030024012 Transgenic plant for use as tool in the generation of mammalian proteins |
| 01/30/2003 | US20030024011 Plant oils with altered oleic acid content |
| 01/30/2003 | US20030024010 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation |
| 01/30/2003 | US20030024009 Genetically engineered plants for use as animal nutrients |
| 01/30/2003 | US20030024008 Amplification of crop yield; obtain nucleotide sequences, generate vector, infect cells, recover transform cells, propagate and monitor seed generation |
| 01/30/2003 | US20030024007 Plant Myb transcription factor homologs |
| 01/30/2003 | US20030024006 Gene switches |
| 01/30/2003 | US20030024004 ZmAxig1 polynucleotides and methods of use |
| 01/30/2003 | US20030024003 Moss genes from Physcomitrella patens encoding proteins involved in the regulation of cell division, growth and biomass formation in plants |
| 01/30/2003 | US20030024002 Method of preparing a somatic cell for nuclear transfer |
| 01/30/2003 | US20030024001 Animal models for use in the treatment of psychological and nervous system disorders |
| 01/30/2003 | US20030024000 Animal models for use in the treatment of injuries and psoriasis |
| 01/30/2003 | US20030023999 Transgenic mice containing GNB1 gene disruptions |
| 01/30/2003 | US20030023998 Transgenic mice containing 5-HT-2B gene disruptions |
| 01/30/2003 | US20030023997 Transgenic c. elegans as a model organism for investigations on alzheimer's disease |
| 01/30/2003 | US20030023995 Animal model for use in the diagnosis and treatment of cell proliferative and nervous system disorders |
| 01/30/2003 | US20030023993 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation |
| 01/30/2003 | US20030023992 Novel G protein-coupled receptors |
| 01/30/2003 | US20030023990 Jnk3 modulators and methods of use |
| 01/30/2003 | US20030023387 Computer-assisted means for assessing lifestyle risk factors |
| 01/30/2003 | US20030023089 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes |
| 01/30/2003 | US20030023077 Used to extract DNA from dried biological samples on solid substrates, including but not limited to, buccal smears, semen and especially blood |
| 01/30/2003 | US20030023076 Method for sequencing reaction cleanup by constant pressure differential ultrafiltration |
| 01/30/2003 | US20030023074 Galanin receptor GALR3 and nucleotides encoding same |
| 01/30/2003 | US20030023073 Growth differentiation factor-15 |
| 01/30/2003 | US20030023070 For diagnosis, prophylaxis and therapy; therapy of cancer |
| 01/30/2003 | US20030023065 Novel human ATPase proteins and polynucleotides encoding the same |
| 01/30/2003 | US20030023063 Novel human kinases and polynucleotides encoding the same |
| 01/30/2003 | US20030023062 For diagnosis, drug screening, clinical trial monitoring, the therapy of physiological disorders or infectious disease |
| 01/30/2003 | US20030023061 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 01/30/2003 | US20030023058 For therapy of cancer |
| 01/30/2003 | US20030023057 Used in assaying for cancer, such as melanoma |
| 01/30/2003 | US20030023056 In immunogenic preparations or diagnostic applications |
| 01/30/2003 | US20030023055 For use in cancer therapy |
| 01/30/2003 | US20030023049 Site specific protein modification |
| 01/30/2003 | US20030023047 For prevention of influenza virus binding to cells, therapy of schizophrenia and diagnosing chronic viral disease associated with development of cancer |
| 01/30/2003 | US20030023038 For therapy of undesired cell proliferation; for stimulation and inhibition of lymphocytes |
| 01/30/2003 | US20030023034 p27 (Kip1) -FKBP-12 protein complexes |
| 01/30/2003 | US20030023033 Novel class II cytokine receptors and uses thereof |
| 01/30/2003 | US20030023032 LuxO-sigma54 interactions and methods of use |
| 01/30/2003 | US20030022870 Methods of treating cardiac disorders |
| 01/30/2003 | US20030022861 Delivery of genetic material via solution of dextrin derivatives; gene therapy; immunotherapy |
| 01/30/2003 | US20030022860 CD40 binding molecules and CTL peptides for treating tumors |
| 01/30/2003 | US20030022859 Method for increasing the gene expression of transfected genes |
| 01/30/2003 | US20030022858 Genes involved in the DNA regulation cascade (cell cycle disorders, DNA repair, tumorigenesis/tumor progression) which are associated with pathophysiology phenotype of Fanconi anaemia |
| 01/30/2003 | US20030022855 Melanoma differentiation associated gene-5 (mda-5) nucleic acids, proteins, and gene promoters for induction of apoptotic cell death |
| 01/30/2003 | US20030022853 Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes |
| 01/30/2003 | US20030022852 Biodegradable immunomodulatory formulations and methods for use thereof |
| 01/30/2003 | US20030022850 Isolated nucleic acid molecule that hybridizes under stringent conditions or shares 80% sequence identity with a defined genomic region upstream of coding region of G-CSF gene, and DNA construct containing that DNA molecule as target |
| 01/30/2003 | US20030022849 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/30/2003 | US20030022848 Antisense oligonucleotide modulation of tumor necrosis factor-alpha (TNF-alpha) expression |
| 01/30/2003 | US20030022841 Growth differentiation factor, Lefty-1 |
| 01/30/2003 | US20030022836 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 01/30/2003 | US20030022830 Methods for enhancing functional recovery following central nervous system ischemia or trauma |
| 01/30/2003 | US20030022826 Use of synthetic peptides to induce tolerance to pathogenic T and B cell epitopes of autoantigens or infectious agents |
| 01/30/2003 | US20030022822 Novel compounds |
| 01/30/2003 | US20030022813 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels |
| 01/30/2003 | US20030022812 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels |
| 01/30/2003 | US20030022378 Expression vector for use as transfer tool in genetic engineering |
| 01/30/2003 | US20030022377 Baculovirus-based expression system |
| 01/30/2003 | US20030022376 Viral complex for use in gene therapy |
| 01/30/2003 | US20030022375 Expression vector for use as tool in gene therapy |
| 01/30/2003 | US20030022374 Modulating photoreactivity in a cell |
| 01/30/2003 | US20030022373 Generation of preferential expression vectors; obtain nucleotide sequences, digest, incubate with insertion sequences, ligate, recover vector |
| 01/30/2003 | US20030022368 Suppression of differentiation in pluripotent stem cells; obtain stem cells, incubate with suppressor polypetide, monitor cell differentiation |
| 01/30/2003 | US20030022367 Cells for use as models in the treatment of heart defects |
| 01/30/2003 | US20030022359 Transgenic algae for delivering antigens to an animal |
| 01/30/2003 | US20030022356 Method for producing recombinant virus |
| 01/30/2003 | US20030022355 Vectors and methods for gene transfer |
| 01/30/2003 | US20030022354 Protein c derivatives |
| 01/30/2003 | US20030022351 Alkaline proteases |
| 01/30/2003 | US20030022349 Virulence-associated nucleic acid sequences and uses thereof |
| 01/30/2003 | US20030022348 Modified forms of pullulanase |
| 01/30/2003 | US20030022346 Enzymatic polypeptide for use in detergents, textile processing and papermaking |
| 01/30/2003 | US20030022339 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/30/2003 | US20030022338 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 01/30/2003 | US20030022336 Enzymatic polypeptide for use in the diagnosis of diabetes |
| 01/30/2003 | US20030022332 Polypeptide or use in the treatment prevention and diagnosis of cancer, viral, inflammatory and autoimmune diseqases |
| 01/30/2003 | US20030022331 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022328 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022326 Nucleotide sequences coding polypeptide for use in tumor therapy |
| 01/30/2003 | US20030022325 Nucleotide sequences coding transport protein for use in diagnosis and treatment of cancers, kidney, bone and nervous sysem disorders |
| 01/30/2003 | US20030022323 Generation of 1,3-propanediol; obtain microorganism, transform with vector, propagate in nutrient broth, express vector, recover propanediol |
| 01/30/2003 | US20030022321 Novel compounds |
| 01/30/2003 | US20030022320 Nucleic acid sequences coding polypeptide for use in the generation of preferential amino acids, for use in animal nutrients, pharmocology and medicines |